Table 2 Carrier frequencies for selected HLA alleles in PBC patients and controls.
HLA allele | Carriers in PBC | Carriers in controls | Odds ratio (95% CI) | p value | ||
|---|---|---|---|---|---|---|
HLA-A | n = 1200 | n = 1196 | ||||
A*33:03 † | 88 | (7.3%) | 199 | (16.6%) | 0.40 (0.30–0.52) | 2.35 × 10−12 |
A*02:01/07/18 | 395 | (32.9%) | 293 | (24.5%) | 1.51 (1.26–1.81) | 5.29 × 10−6 |
HLA-B | n = 1200 | n = 1196 | ||||
B*44:03 a | 66 | (5.5%) | 187 | (15.6%) | 0.31 (0.23–0.42) | 7.01 × 10−16 |
B*07:02 | 90 | (7.5%) | 146 | (12.2%) | 0.58 (0.44–0.77) | 1.11 × 10−4 |
HLA-DRB1 | n = 1200 | n = 1194 | ||||
DRB1*13:02 a | 47 | (3.9%) | 175 | (14.7%) | 0.24 (0.17–0.33) | 1.35 × 10−19 |
DRB1*08:03 a | 283 | (23.6%) | 179 | (15.0%) | 1.75 (1.42–2.16) | 1.01 × 10−7 |
DRB1*14:03 | 7 | (0.6%) | 32 | (2.7%) | 0.21 (0.09–0.49) | 5.10 × 10−5 |
DRB1*04:05 | 390 | (32.5%) | 292 | (24.5%) | 1.49 (1.24–1.78) | 1.31 × 10−5 |
HLA-DQA1 | n = 1198 | n = 783 | ||||
DQA1*01:02 a | 173 | (14.4%) | 208 | (26.6%) | 0.47 (0.37–0.59) | 2.20 × 10−11 |
HLA-DQB1 | n = 1199 | n = 1195 | ||||
DQB1*06:04 a | 37 | (3.1%) | 171 | (14.3%) | 0.19 (0.13–0.28) | 1.91 × 10−22 |
DQB1*03:01 a | 144 | (12.0%) | 256 | (21.4%) | 0.50 (0.40–0.63) | 6.76 × 10−10 |
DQB1*06:01 a | 520 | (43.4%) | 403 | (33.7%) | 1.51 (1.27–1.78) | 1.25 × 10−6 |
DQB1*04:01 | 378 | (31.5%) | 280 | (23.4%) | 1.50 (1.25–1.80) | 9.20 × 10−6 |
DQB1*04:02 | 137 | (11.4%) | 87 | (7.3%) | 1.64 (1.24–2.18) | 4.99 × 10−4 |
HLA-DPA1 | n = 1200 | n = 783 | ||||
DPA1*01:03 a | 585 | (48.8%) | 495 | (63.2%) | 0.55 (0.46–0.67) | 2.58 × 10−10 |
HLA-DPB1 | n = 1200 | n = 1196 | ||||
DPB1*04:01 a | 35 | (2.9%) | 131 | (11.0%) | 0.24 (0.17–0.36) | 9.63 × 10−15 |
DPB1*02:01 | 378 | (31.5%) | 485 | (40.6%) | 0.67 (0.57–0.80) | 3.95 × 10−6 |
DPB1*05:01 | 815 | (67.9%) | 729 | (61.0%) | 1.36 (1.15–1.60) | 3.72 × 10−4 |